Multiplex assays can be defined as the type of immunoassay that employs magnetic beads for simultaneously measuring a range of analytes in a single reaction. Multiplex assays are considered to be derivatives of enzyme linked immunosorbent assay (ELISA). However, these are preferred over singleplex ELISA, owing to their advantages such as high throughput, greater output per sample volume, and increased efficiency.
The global multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026, expanding at a CAGR of 7.90% from 2018 to 2026.

Source: Click here